Description: This session discusses the Academy's efforts to address health reform, the latest HIAA activities in the health care debate, and industry implications for proposed legislation. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This session is about supplemental and specialty health products in Japan, the UK, Canada and Australia. It also includes a discussion on health care reform for individual health and long-term care products. From Record of Society of Actuaries Vol. 19, No. 1A.

Description: Presented at October 2000 Annual Meeting. The panel presents the status of recent legislative proposals and current election debates, and then focuses more attention on the potential longer-term directions for the health-care system.

Description: Panel discussion of prospects for cost containment of, and alternatives to, fee-for-service health care, and management of health care under national health insurance. Discussion points include cost containment devices, HMOs, economic impact, cost escalation, self-insurance, stop-loss, claims administration, loss of state premium taxes, and Phase 3 tax problems under NH1.

Description: This session discusses items being promoted by the administration, other politicians, and others interested in the outcome of health care reform. Included is the possible effect on private LTC insurers, LTC taxation, and reporting requirements. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This presentation included discussions on AAA Medicare Reform Task Force, the 2000 Medicare Technical Advisory Panel's review of HCFA's Medicare projections, and prescription drug coverage. From the Record of the Society of Actuaries, Volume 27, No. 1, Session 7

Description: US pharmacy prices have entered a new era of growth driven by Specialty medications. A bevy of state and national regulations have been proposed to address pharmacy pricing, industry structure and transparency.Health actuaries will learn about US pharmacy pricing structure and how proposed legislation could affect future costs. Actuaries that have responsibility for pharmacy rate/budget setting, RFPs or trend projection will benefit from a deeper understanding of the US pharmacy market landscape and gain an international perspective.

Description: In this session actuarial and benefit design issues of various health care reform proposals will be identified. An update on task force activities will be presented. The relative richness of benefits will be discussed. Key benefit components such as mental illness coverages will be featured. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This presentation discusses National Health Insurance comparing the Canadian experience with possible U.S. developments. From Record of Society of Actuaries, Vol. 6, No. 2.

Description: Panelists will discuss and stimulate audience discussion on the potential roles and opportunities for actuaries during and after health care reform. Included is a perspective from Cananda's experience. From Record of Society of Actuaries Vol. 20, No. 3B.